DK1100499T3 - Anvendelse af eletriptan til forebyggelse af migrænetilbagevendelse - Google Patents

Anvendelse af eletriptan til forebyggelse af migrænetilbagevendelse

Info

Publication number
DK1100499T3
DK1100499T3 DK99922459T DK99922459T DK1100499T3 DK 1100499 T3 DK1100499 T3 DK 1100499T3 DK 99922459 T DK99922459 T DK 99922459T DK 99922459 T DK99922459 T DK 99922459T DK 1100499 T3 DK1100499 T3 DK 1100499T3
Authority
DK
Denmark
Prior art keywords
eletriptan
prevention
migraine recurrence
migraine
recurrence
Prior art date
Application number
DK99922459T
Other languages
Danish (da)
English (en)
Inventor
Neville Colin Jackson
Stephen Uden
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK1100499T3 publication Critical patent/DK1100499T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
DK99922459T 1998-07-30 1999-06-14 Anvendelse af eletriptan til forebyggelse af migrænetilbagevendelse DK1100499T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9816556.6A GB9816556D0 (en) 1998-07-30 1998-07-30 Therapy

Publications (1)

Publication Number Publication Date
DK1100499T3 true DK1100499T3 (da) 2004-06-14

Family

ID=10836395

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99922459T DK1100499T3 (da) 1998-07-30 1999-06-14 Anvendelse af eletriptan til forebyggelse af migrænetilbagevendelse

Country Status (36)

Country Link
EP (3) EP1466601A3 (fr)
JP (1) JP3824863B2 (fr)
KR (2) KR20030078876A (fr)
CN (2) CN1155379C (fr)
AP (1) AP1402A (fr)
AT (1) ATE261304T1 (fr)
AU (1) AU3952199A (fr)
BG (1) BG65309B1 (fr)
BR (1) BR9912588A (fr)
CA (1) CA2338901C (fr)
CZ (1) CZ2001357A3 (fr)
DE (1) DE69915486T2 (fr)
DK (1) DK1100499T3 (fr)
EA (2) EA200201149A1 (fr)
EE (1) EE04703B1 (fr)
ES (1) ES2214027T3 (fr)
GB (1) GB9816556D0 (fr)
GE (2) GEP20063719B (fr)
HK (1) HK1038198A1 (fr)
HR (1) HRP20010079A2 (fr)
HU (1) HUP0103424A3 (fr)
ID (1) ID26996A (fr)
IL (1) IL140169A0 (fr)
IS (1) IS2253B (fr)
NO (1) NO20010489L (fr)
NZ (2) NZ508736A (fr)
OA (1) OA11576A (fr)
PL (1) PL194611B1 (fr)
PT (1) PT1100499E (fr)
SG (1) SG125910A1 (fr)
SK (1) SK1182001A3 (fr)
TR (1) TR200100314T2 (fr)
TW (2) TWI248362B (fr)
UA (1) UA76399C2 (fr)
WO (1) WO2000006161A1 (fr)
YU (2) YU20303A (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
GB9915231D0 (en) * 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
CN1176649C (zh) * 2002-10-16 2004-11-24 上海医药工业研究院 舒马普坦干粉吸入剂及其制备方法
EP1575566B1 (fr) * 2002-12-26 2012-02-22 Pozen, Inc. Formes galeniques multicouches contenant de naproxene et des triptanes
MXPA05010070A (es) 2003-04-11 2005-11-23 Pfizer Combinacion farmaceutica.
GB2407498B (en) * 2003-10-30 2008-06-11 Cipla Ltd Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
FR2926721B1 (fr) * 2008-01-30 2011-07-22 Philippe Perovitch Forme galenique pour l'adminsitration par voie trans-muqueuse de triptans
CN102088966B (zh) 2008-06-20 2015-06-10 阿尔法制药有限公司 药物制剂
WO2011048496A1 (fr) * 2009-10-23 2011-04-28 Fortuderm, Ltd. Triptans pour le traitement du psoriasis
US10561618B2 (en) * 2012-04-18 2020-02-18 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
CN103385876B (zh) * 2012-05-08 2016-01-13 四川滇虹医药开发有限公司 一种夫罗曲坦的药物组合物及其制备方法
CN104523709A (zh) * 2014-12-22 2015-04-22 青岛正大海尔制药有限公司 一种含有琥珀酸夫罗曲坦的复方缓释制剂
CN109689036A (zh) 2016-07-11 2019-04-26 康特拉医药公司 用于治疗早晨运动不能的脉冲药物输送系统

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT64326A (en) * 1990-10-15 1993-12-28 Pfizer Process for production indole derivatives and pharmaceutical preparations containing these compounds
ES2106818T3 (es) * 1991-10-30 1997-11-16 Glaxo Group Ltd Composicion multicapa que contiene antagonistas de histamina o secotina.
US5464633A (en) * 1994-05-24 1995-11-07 Jagotec Ag Pharmaceutical tablets releasing the active substance after a definite period of time
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US5698571A (en) * 1994-10-05 1997-12-16 Eli Lilly And Company 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine
US5744482A (en) * 1994-10-05 1998-04-28 Eli Lilly And Company Serotonin agonist in combination with a tachykinin receptor antagonist in the treatment or prevention of migraine
IL127956A0 (en) * 1996-07-11 1999-11-30 Farmarc Nederland Bv Inclusion complex containing indole selective serotonin agonist
ATE206921T1 (de) * 1997-07-03 2001-11-15 Pfizer Eletriptanhemisulfat und kaffein enthaltende pharmazeutische zusammenstellungen
US6514530B2 (en) * 1997-09-09 2003-02-04 Alza Corporation Dosage form comprising means for changing drug delivery shape

Also Published As

Publication number Publication date
CN1155379C (zh) 2004-06-30
TW537893B (en) 2003-06-21
PT1100499E (pt) 2004-06-30
YU6401A (sh) 2004-03-12
CA2338901C (fr) 2008-02-19
TR200100314T2 (tr) 2001-06-21
NO20010489L (no) 2001-03-26
SG125910A1 (en) 2006-10-30
AU3952199A (en) 2000-02-21
EE04703B1 (et) 2006-10-16
KR20030078876A (ko) 2003-10-08
NZ508736A (en) 2003-09-26
EA004036B1 (ru) 2003-12-25
GB9816556D0 (en) 1998-09-30
HK1038198A1 (en) 2002-03-08
NZ527625A (en) 2005-01-28
BG105277A (en) 2001-11-30
HRP20010079A2 (en) 2002-02-28
YU20303A (sh) 2006-08-17
UA76399C2 (en) 2006-08-15
CA2338901A1 (fr) 2000-02-10
IS5771A (is) 2000-12-15
ID26996A (id) 2001-02-22
GEP20043157B (en) 2004-01-26
EP1466601A3 (fr) 2005-04-13
CZ2001357A3 (cs) 2001-10-17
CN1522697A (zh) 2004-08-25
EP1100499A1 (fr) 2001-05-23
HUP0103424A3 (en) 2003-05-28
KR20010079582A (ko) 2001-08-22
EE200100061A (et) 2002-06-17
JP3824863B2 (ja) 2006-09-20
CN1309560A (zh) 2001-08-22
BG65309B1 (bg) 2008-01-31
EA200201149A1 (ru) 2003-02-27
PL345803A1 (en) 2002-01-02
JP2002521446A (ja) 2002-07-16
GEP20063719B (en) 2006-01-10
DE69915486D1 (de) 2004-04-15
IL140169A0 (en) 2002-02-10
KR100441732B1 (ko) 2004-07-27
PL194611B1 (pl) 2007-06-29
TW200300674A (en) 2003-06-16
EP1435237A1 (fr) 2004-07-07
BR9912588A (pt) 2001-05-02
TWI248362B (en) 2006-02-01
OA11576A (en) 2004-07-01
SK1182001A3 (en) 2001-10-08
EP1466601A2 (fr) 2004-10-13
WO2000006161A1 (fr) 2000-02-10
EA200100089A1 (ru) 2001-08-27
AP2001002056A0 (en) 2001-03-31
ATE261304T1 (de) 2004-03-15
DE69915486T2 (de) 2005-03-03
EP1100499B1 (fr) 2004-03-10
IS2253B (is) 2007-06-15
ES2214027T3 (es) 2004-09-01
NO20010489D0 (no) 2001-01-29
AP1402A (en) 2005-04-29
HUP0103424A2 (hu) 2002-02-28

Similar Documents

Publication Publication Date Title
DE69932032D1 (de) Inhibitoren der alpha4 vermittelten zelladhäsion
DK1001934T3 (da) Indolforbindelser som COX-2-inhibitorer
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
ID20637A (id) Metode untuk menghambat pembentukan sulfida biogenik
NO20001979D0 (no) Anvendelse av inhibitorer av renin-angiotensin-systemet
DK1100499T3 (da) Anvendelse af eletriptan til forebyggelse af migrænetilbagevendelse
BR9707514A (pt) Inibidor de neovascularizacão
DK199800837A (da) Anlæg til behandling af emner
ID21424A (id) Konfigurasi katup gabungan untuk unit siklus-uap
DK1054868T3 (da) Substituerede pyridinoarylpiperaziner egnede til behandling af prostatahyperplasi
DK0981950T3 (da) Fremgangsm,åde til formering af phyllocactus
NO307859B1 (no) FremgangsmÕte for beregning av varighet av oppkoblinger
TR199902015A3 (tr) Aril-sikloheksilamin türevlerinin CNS bozukluklarina karsi kullanilmasi.
DK1500396T3 (da) Reboxetin til behandling af migrænehovedpiner
SI1100499T1 (en) Use of eletriptan for the prevention of migraine recurrence
DE69905397D1 (de) Selektive inhibitoren des mmp-12
NO20011268D0 (no) Forbindelse til behandling av depresjon
DK1133290T3 (da) Anvendelse af acetylcholinesterase-inhibitorer til behandling af delirier
NO980820L (no) Dusjhode
FI3524U1 (fi) Yhdistelmäkoura
DK199900400U3 (da) System til beskyttelse af træværk
IT1303963B1 (it) Dispositivo per il serraggio di pezzi o simili .
NO970186D0 (no) Varmegjenvinner for dusj
DK199901871A (da) Fallerør til lås
IT1302348B1 (it) Procedimento di inertizzazione di amianti mediante applicazioni dimicroonde.